Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, and Hypobaria

Sponsor
Direction Centrale du Service de Santé des Armées (Other)
Overall Status
Unknown status
CT.gov ID
NCT03311347
Collaborator
Uppsala University Hospital (Other), Percy Hospital (Other)
80
2
2
51.6
40
0.8

Study Details

Study Description

Brief Summary

The primary aim of this project is to get further knowledge of the physiology of flight atelectasis and its prevention. We seek to: 1) assess whether low levels of positive pressure breathing can prevent atelectasis formation in humans during exposure to hyperoxia and +Gz-accelerations. 2) get further knowledge on the effects of hypobaria on regional ventilation and perfusion.

A secondary aim is to evaluate the effect of anti G-trouser inflation on ventilation and regional perfusion.

Condition or Disease Intervention/Treatment Phase
  • Other: +Gz accelerations and positive pressure breathing
N/A

Detailed Description

The effect of positive pressure breathing on lung function is being studied, when applied during exposure to hyperoxia and +Gz-accelerations. Focus is on lung tissue compression, ventilation and regional perfusion. In addition, the influence of hypobaria on these parameters is assessed.

This study is conducted in accordance with the amended Declaration of Helsinki. The Ethics Committee Ile-de-France III (ref. 3274) and the French National Agency for Drug Safety ANSM have approved the protocol (ref. ID RCB 2015-A00485-44 and ANSM 151046B-32).

Primary aim, item 1: Experiments are conducted in a human centrifuge. The protocol mimics a routine peacetime flight in combat aircraft, and includes 1hr05 min at +1Gz followed by 10-min exposure to +1.4 to +3.5Gz . Subjects are exposed three times to this sequence, breathing at positive pressure levels of 0, 5 or 10 hPa. Two groups of sixteen healthy male non-smoking volunteers, wearing anti-G trousers, are studied and compared: group 1 breathes air, group 2 100% O2.

Primary aim, item 2: Experiments are conducted in a hypobaric chamber. Sixteen healthy male non-smoking volunteers are exposed to four conditions: 0 or 15,000 ft altitude, breathing air or 100%O2. Protocol duration is 1h15min. Positive breathing pressure can be applied depending on the results of the experiments of item 1.

Secondary aim: Experiments are conducted in a human centrifuge. Sixteen healthy male non-smoking volunteers are exposed to four conditions: uninflated or inflated anti-G trousers (175 hPa), +1 or +3.5 Gz for 3 min.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two arms are studied, breathing air or 100%O2. In each arm, subjects are studied at two occasions: with and without positive pressure breathing. These occasions are randomized.Two arms are studied, breathing air or 100%O2. In each arm, subjects are studied at two occasions: with and without positive pressure breathing. These occasions are randomized.
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Influence of Hyperoxia and Hypobaria on Atelectasis Occurrence and Mitigation of Atelectasis Formation
Actual Study Start Date :
Sep 14, 2015
Anticipated Primary Completion Date :
Jun 30, 2019
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: 100%O2 breathing

Primary aim, item 1

Other: +Gz accelerations and positive pressure breathing

Experimental: Air breathing

Primary aim, item 1

Other: +Gz accelerations and positive pressure breathing

Outcome Measures

Primary Outcome Measures

  1. atelectasis formation (change between pre and post-protocol) [pre-protocol (baseline) and 1h30 min after centrifuge stop]

    computerized tomography: 0-5 scale for size and localization

  2. change in pulmonary ventilation between 1 Gz, 1.6 Gz and 3.5 Gz [pre-protocol (baseline), baseline + 1hr, baseline +1h10 min, baseline +1h15 min]

    electrical impedance tomography: deltaZ on regions of interest

  3. change in pulmonary tissue density from baseline at centrifuge stop and 1h30 min after stop [pre protocol (baseline), at centrifuge stop (baseline + 1h15 min) and 1h30 min after centrifuge stop]

    ultrasound: number of lung comets + localization

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • normal lung function checked by pulmonary function tests.

  • normal ECG

  • normal clinical examination

Aim 1 exclusion criteria:
  • smoking

  • myopia

  • past medical history of heart or lung disease

  • current medical treatment for heart or lung disease

  • past medical history of back pain or spine trauma or disease

  • otitis

  • bad tolerance to +Gz accelerations (G-induced loss of consciousness, motion sickness)

  • claustrophobia in the centrifuge gondola

Aim 2 exclusion criteria:
  • smoking

  • past medical history of heart or lung disease

  • current medical treatment for heart or lung disease

  • otitis

  • bad tolerance to the altitude chamber (15,000 ft): ear pain, claustrophobia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Armed Forces Biomedical Research Institute Brétigny-sur-Orge France 91 223
2 Department of Radiology, Percy hospital Clamart France 92140

Sponsors and Collaborators

  • Direction Centrale du Service de Santé des Armées
  • Uppsala University Hospital
  • Percy Hospital

Investigators

  • Study Chair: Dominique Felten, MD, Armed Forces Biomedical Research Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Direction Centrale du Service de Santé des Armées
ClinicalTrials.gov Identifier:
NCT03311347
Other Study ID Numbers:
  • PDH1-SMO2-0714
First Posted:
Oct 17, 2017
Last Update Posted:
May 14, 2019
Last Verified:
May 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Direction Centrale du Service de Santé des Armées
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 14, 2019